Researchers at Georgetown University's Lombardi Comprehensive Cancer Centre and associates have discovered that a form of glucose, a type of sugar, is intricately linked to a pathway used to construct DNA molecules as part of their investigation into the complexities of biochemical pathways
The research scholar, Priyanka Khanna of NIT, Raipur, developed a model conducive to the prediction of breast cancer (through images, the size of the tumour, a few blood parameters and other factors) and finding out whether the patient is responsive to Chemotherapy or not.
Researchers discovered that cancer frequently sends substances into the bloodstream that pathologically alter the liver, putting it in an inflammatory condition, causing fat to build up, and interfering with its regular detoxification functions.
Researchers at Weill Cornell Medicine found that cancer often releases molecules into the bloodstream that pathologically modify the liver, sending it into an inflammatory state, causing fat accumulation, and disrupting its typical detoxification processes. This finding sheds light on one of
Cisplatin is commonly used as a chemotherapeutic drug in the treatment of many solid tumours, including bladder, ovarian, and esophageal tumours. However, when it is metabolised by an enzyme called "cysteine conjugate beta-lyase 1 (CCBL1)," it is transformed to "thiol-cisplatin," a highly ac
Anthracyclines, a particular class of chemotherapy that breaks the DNA in cancer cells, have been reported to increase the risk of heart failure among young adult cancer survivors (between the ages of 18 and 39 at diagnosis) by 2.6 times.
bout 1 in 26 people have epilepsy, and the most common type, temporal lobe epilepsy (TLE), is frequently ineffectively treated with anti-seizure drugs. Neurosurgery may be necessary for patients with this type of epilepsy in order to stop their seizures. Uncertainty surrounds the causes and
A recent study suggested that spinal cord stimulation (SCS) may be effective in lowering chronic pain in persons receiving active therapy with a standard anti-cancer medicine, according to researchers at Johns Hopkins University School of Medicine.
Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.
Gurgaon (Haryana) [India], April 14 (ANI/BusinessWire India): Art of Healing Cancer, a globally renowned Precision and integrative oncology institution located in Gurgaon, underscores the possible benefits of incorporating the anti-malarial drug, Artesunate, into cancer treatments. This insi
Chemotherapy treatments produce strong side effects. A new agent that accumulates in the tumour tissue and is activated there by ultrasound waves does not have this problem.